Philips and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), a unit of Tata Memorial Centre, have introduced Spectral CT imaging to support cancer care in India. The collaboration focuses on diagnosis, disease detection and clinical decision-making for patients with complex cancers.
As India faces a growing burden of cancer and multi-system diseases, timely diagnosis remains critical. Diagnostic delays can contribute to patient harm, while repeat imaging may increase radiation exposure, patient anxiety and treatment timelines, particularly in tertiary care centres.
Philips Spectral CT 7500 enables clinicians to capture spectral information during routine CT scans. This allows disease characterisation from a single scan and supports diagnostic decisions without increasing radiation dose. It provides insight from one scan, reducing repeat imaging and enabling full body examinations in approximately two seconds. Studies show 36 per cent fewer additional diagnostic procedures in complex cancer evaluations, reducing patient anxiety, radiation exposure and treatment delays.
Bharath Sesha, Managing Director, Philips Indian Subcontinent, said, “At Philips, we are committed to enabling precision diagnosis by providing advanced imaging capabilities to leading healthcare institutions. Our collaboration with Tata Memorial Cancer Centre demonstrates how technology can support clinicians in making faster, more accurate decisions, while enhancing patient safety and workflow efficiency. By embedding Spectral CT into routine practice, we aim to help healthcare teams reduce delays, minimise unnecessary scans and improve access to timely diagnosis — supporting India’s broader goal of strengthening diagnostic infrastructure and improving outcomes.”
Dr Pankaj Chaturvedi, Director, ACTREC, Tata Memorial Centre, said, “Accurate and timely diagnosis is the cornerstone of effective cancer care. The commissioning of advanced Spectral CT at ACTREC reflects our commitment to integrating cutting-edge technology into clinical practice for the direct benefit of our patients. By enabling deeper diagnostic insights from a single scan while improving efficiency, this platform will help clinicians make faster, more informed treatment decisions. We dedicate this technology to the service of our patients and reaffirm our mission to advance cancer care through innovation that is precise, compassionate, and future-ready.”
The introduction of Spectral CT will support oncology, cardiology, neurology and emergency care. During a joint clinical programme on Spectral CT held at ACTREC on 7 February 2026, ‘Spectral CT: Clinical Publication Compendium’ was unveiled in the presence of radiologists. The compendium includes over 770 peer-reviewed publications and white papers from across the globe, outlining the use of detector-based spectral CT in diagnostic certainty, dose and contrast optimisation, reduced follow-up examinations and workflow across clinical applications.
Philips stated that it remains committed to advancing India’s diagnostic ecosystem. ACTREC continues to adopt technologies to support patient care and oncology practice in India.